Displaying all 2 publications

Abstract:
Sort:
  1. Norasikin Ab Azis, Mohd Saleh Ahmad Kamal, Zurain Radjeni, Ahmed Mediani, Renu Agarwal
    MyJurnal
    Introduction: This study examined the association of losartan induced changes in urinary
    metabolomic profile with the changes in blood pressure (BP) and renin-angiotensinaldosterone system (RAAS) in spontaneously hypertensive rats (SHR). Methods: Male SHR
    were administered with either 0.5 mL of distilled water (control group, n=6) or 10 mg.kg-1 of
    losartan (group 2, n=6) daily by oral gavage for 4 weeks. Body weight, BP, food and water
    intake were measured weekly. At week 4, urine was collected for urinary electrolyte analysis
    and metabolite profiling, after which the animals were euthanised by decapitation and blood
    was collected for analysis of components of RAAS and electrolyte concentrations. Urine
    metabolite profile of SHR was determined using proton nuclear magnetic resonance (
    1H-NMR)
    spectrometry combined with multivariate data analysis. Results: At week 4, losartan-treated
    SHR had significantly lower BP than non-treated SHR. There were no differences in water
    and food intake, body weight, serum and urinary electrolyte concentrations or in their urinary
    excretions between the two groups. No differences were evident in the components of RAAS
    except that the angiotensinogen level was significantly higher in losartan-treated SHR
    compared to non-treated SHR. Orthogonal partial least squares discriminant analysis (OPLSDA) showed clear separation of urinary metabolites between control and losartan-treated
    SHR. Losartan-treated SHR group was separated from the control group by changes in the
    intermediates involved in glycine, serine and threonine metabolism. Conclusion:
    Antihypertensive effect of losartan in SHR seems to be associated with changes in urinary
    metabolite profile, particularly involving the metabolism of glycine, serine and threonine.
  2. Lee, Kah Nyan, Maulidiani, Faridah Abas, Ahmed, Mediani, Leong, Sze Wei, Intan Safinar Ismail, et al.
    MyJurnal
    The ocean has an exceptional resource with various groups of natural products that are potentially useful for biomedical and other applications. Marine sponges have prominent characteristic natural products with high diversity. They produce many vital therapeutic metabolites with prominent biological activities. Marine invertebrates and microbial communities are the primary producers of such metabolites. Among the richest sources of these metabolites, class Demospongiae and the order Haplosclerida and genus Xestopongiae from family Petrosiidae are of interest. This review summarizes the research that has been conducted on two classes, eight orders, twelve families and fourteen genera of marine sponges available in the South East Asia region, covering the literature of the last 20 years. Ninety-five metabolites including alkaloids, sterols, terpenoids, quinones isolated from marine sponges collected in South East Asia along with their bioactivities especially cytotoxicity and antibacterial activities were reported in this review. Chemistry and biology are highly involved in studying marine sponges. Thus, tight collaboration is needed for understanding their taxonomy aspects. This review will outline chemistry and biological aspects, challenge, limitation, new idea and a clear future perspective on the discovery of new drugs from South East Asia’s marine sponges.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links